glp 1 drugs mechanism Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Mechanism of action of GLP-1

Thank you Happy Mammoth

The global GLP-1 market is estimated to grow from USD 49.3 billion in the current year to USD 157

Additionally, several key clinical trial readouts delivered compelling data across multiple indications, for example (see Figure 1): Semaglutide: STEP-HFpEF (functional benefits in HFpEF), STEP-9 (pain reduction in knee osteoarthritis), STEP-10 (reversion to normoglycaemia in pre-diabetic, obese patients), ESSENCE (resolution of MASH, improvement in fibrosis) Tirzepatide: SUMMIT (risk reduction in HFpEF outcomes

Sources for Figure 218

You've heard the buzz about semaglutide and tirzepatide for weight loss, but let's clear up the myths